A reason to explain the selective toxicity of CPZ toward GBM cells could be envisaged in the peculiar pattern of expression of PK isoforms postulated for cancer cells, where a higher PKM2/PKM1 ratio is widely described [33, 34]. The gene discussed is CPZ; the disease is glioblastoma.